Severe hypercalcemia associated with uterine leiomyoma in pregnancy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21252794.
- Also identified by DOI 10.1097/AOG.0b013e3181fd29ae.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Uterine leiomyomas are the most common pelvic tumor, and a frequent indication of the need for gynecologic surgery. Although usually asymptomatic, life-threatening cases can occur. We present a case of critical hypercalcemia associated with a leiomyoma during pregnancy with the intention of highlighting the endocrinology of leiomyomas, features shared with malignant neoplasms, and the potential for effects on obstetric outcomes. A 32-year-old gravid woman with a large leiomyoma presented at 33 5/7 weeks of gestation with critical hypercalcemia requiring intensive care. Postpartum myomectomy cured her hypercalcemia, which was driven by parathyroid hormone-related protein (PTHrP) produced by the tumor. Obstetricians should be aware of the existence of humoral hypercalcemia related to leiomyomas and the potential effects on pregnancy.
Medical subject headings
- Hypercalcemia
- Leiomyoma
- Pregnancy Complications, Neoplastic
- Uterine Neoplasms